379 related articles for article (PubMed ID: 17573517)
21. Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.
Meguid RA; Hooker CM; Harris J; Xu L; Westra WH; Sherwood JT; Sussman M; Cattaneo SM; Shin J; Cox S; Christensen J; Prints Y; Yuan N; Zhang J; Yang SC; Brock MV
Chest; 2010 Sep; 138(3):500-9. PubMed ID: 20507946
[TBL] [Abstract][Full Text] [Related]
22. Survival of patients with true pathologic stage I non-small cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors in stage III non-small-cell lung cancer.
Ademuyiwa FO; Johnson CS; White AS; Breen TE; Harvey J; Neubauer M; Hanna NH
Clin Lung Cancer; 2007 Sep; 8(8):478-82. PubMed ID: 17922971
[TBL] [Abstract][Full Text] [Related]
24. XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers.
Yeh KT; Wu YH; Lee MC; Wang L; Li CT; Chen CY; Lee H
Ann Surg Oncol; 2012 Mar; 19(3):734-42. PubMed ID: 21861227
[TBL] [Abstract][Full Text] [Related]
25. Molecular profiles of non-small cell lung cancers in cigarette smoking and never-smoking patients.
Szymanowska-Narloch A; Jassem E; Skrzypski M; Muley T; Meister M; Dienemann H; Taron M; Rosell R; Rzepko R; Jarząb M; Marjański T; Pawłowski R; Rzyman W; Jassem J
Adv Med Sci; 2013; 58(2):196-206. PubMed ID: 24451080
[TBL] [Abstract][Full Text] [Related]
26. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?
Hsu LH; Chu NM; Liu CC; Tsai SY; You DL; Ko JS; Lu MC; Feng AC
Lung Cancer; 2009 Nov; 66(2):262-7. PubMed ID: 19299032
[TBL] [Abstract][Full Text] [Related]
27. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
[TBL] [Abstract][Full Text] [Related]
28. Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role.
Vesselle H; Freeman JD; Wiens L; Stern J; Nguyen HQ; Hawes SE; Bastian P; Salskov A; Vallières E; Wood DE
Clin Cancer Res; 2007 Jun; 13(11):3255-63. PubMed ID: 17545531
[TBL] [Abstract][Full Text] [Related]
29. Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer.
Lee SJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Yoo CG; Han SK; Kim YW
J Thorac Oncol; 2014 Jun; 9(6):812-7. PubMed ID: 24807154
[TBL] [Abstract][Full Text] [Related]
30. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer.
Tsao AS; Liu D; Lee JJ; Spitz M; Hong WK
Cancer; 2006 Jun; 106(11):2428-36. PubMed ID: 16634096
[TBL] [Abstract][Full Text] [Related]
31. The relevance of "Nonsmoking-associated lung cancer" in India: a single-centre experience.
Krishnamurthy A; Vijayalakshmi R; Gadigi V; Ranganathan R; Sagar TG
Indian J Cancer; 2012; 49(1):82-8. PubMed ID: 22842173
[TBL] [Abstract][Full Text] [Related]
32. Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma.
Yoshino I; Kawano D; Oba T; Yamazaki K; Kometani T; Maehara Y
Ann Thorac Surg; 2006 Apr; 81(4):1189-93. PubMed ID: 16564239
[TBL] [Abstract][Full Text] [Related]
33. The effect of smoking on prostate cancer survival: a cohort analysis in Barcelona.
Murta-Nascimento C; Romero AI; Sala M; Lorente JA; Bellmunt J; Rodero NJ; Lloreta J; Hospital À; Burón A; Castells X; Macià F
Eur J Cancer Prev; 2015 Jul; 24(4):335-9. PubMed ID: 25075878
[TBL] [Abstract][Full Text] [Related]
34. Former smokers with non-small-cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis.
Zheng S; Wang R; Zhang Y; Pan Y; Cheng C; Zheng D; Sun Y; Chen H
Cancer Med; 2016 Aug; 5(8):2117-25. PubMed ID: 27227356
[TBL] [Abstract][Full Text] [Related]
35. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
36. Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis.
Subramanian J; Morgensztern D; Goodgame B; Baggstrom MQ; Gao F; Piccirillo J; Govindan R
J Thorac Oncol; 2010 Jan; 5(1):23-8. PubMed ID: 19934774
[TBL] [Abstract][Full Text] [Related]
37. [Staging with 18F-FDG-PET/CT influences stage-specific survival in advanced non-small cell lung cancer (NSCLC)].
Tönnies S; Bauer TT; Misch D; Boch C; Blum T; Bittner RC; Förster GJ; Kollmeier J
Pneumologie; 2012 Apr; 66(4):212-7. PubMed ID: 22477481
[TBL] [Abstract][Full Text] [Related]
38. Surgery for non-small cell lung cancer in younger patients: what are the differences?
Dell'Amore A; Monteverde M; Martucci N; Davoli F; Caroli G; Pipitone E; Bini A; Stella F; Dell'Amore D; Casadio C; Rocco G
Heart Lung Circ; 2015 Jan; 24(1):62-8. PubMed ID: 25130384
[TBL] [Abstract][Full Text] [Related]
39. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
40. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
